NOVEMBER 2016 Features
Announcements
Contact Us
|
Innovative Molecular and Cellular Analysis Techniques for Basic and Clinical Cancer Research Applications Due: February 28, 2017; May 26, 2017; September 26, 2017 Expiration Date: September 27, 2017
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Applications Due: February 28, 2017; May 26, 2017; September 26, 2017
Expiration Date: September 27, 2017
Innovative Technologies for Cancer-Relevant Biospecimen Science
Applications Due: February 28, 2017; May 26, 2017; September 26, 2017
Expiration Date: September 27, 2017
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research
Applications Due: February 28, 2017; May 26, 2017; September 26, 2017
Expiration Date: September 27, 2017
PA-17-041
(R01)
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
Expiration Date: January 8, 2020
Addressing Health Disparities through Effective Interventions Among Immigrant Populations
Expiration Date: January 8, 2020
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery
Expiration Date: January 8, 2020
|
Deadline extended to December 1, 2016
|
Publication of the Revised NIH Grants Policy Statement for FY2017
NOT-OD-17-022 NIH Implementation of Final Research Performance Progress Reports
|
NOT-CA-17-001 Epidemiology Research on Novel Infectious Agents and Cancer Occurrence and Outcomes Revised response due date: December 15, 2016
Patient-Centered Outcomes Research Institute (PCORI) Data Access and Data Sharing Policy Public comment period ends December 15, 2016
Strategies for NIH Data Management, Sharing, and Citation Responses due December 29, 2016 |
December 1, 2016
December 5-7, 2016
December 9, 2016
December 13, 2016
December 14, 2016
9th Annual Conference on Science of Dissemination and Implementation in Health December 14-15, 2016 Washington, DC
Deep Sequencing of 10,000 Human Genomes and Sequencing Quality Standards for Human Variation Discovery January 13, 2017
Save-the-Date: 5th International Conference on Ambulatory Monitoring of Physical Activity and Movement June 21-23, 2017 Bethesda, MD Note: Abstracts for papers, symposia, and pre-workshops are due December 31, 2016 |
Leveraging Open Data Science to Accelerate Innovation at NIH and Beyond NIH Input Output Blog
NCI Cancer Currents Blog
NIH Open Mike Blog
NIH Open Mike Blog |
The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) funds research in human populations to understand the causes of cancer and related outcomes.
The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions. |
|
|
Annual Meeting Focuses on New Technologies & Policies Influencing Cancer Epidemiology Studies
|
The Consortium provides a coordinated, interdisciplinary approach to tackling important scientific questions, using economies of scale and opportunities to quicken the pace of research. The Consortium's mission is to promote communication and collaboration between member cohorts, identify common problems, and recommend possible solutions.
The Annual Meeting was an opportunity for Consortium members and other interested individuals to discuss scientific progress and new opportunities for collaboration.
Key topics on the
agenda included:
- Updates on a planned cohort by NCI's Division of Cancer Epidemiology and Genetics and the All of Us Research Program (formerly the NIH Precision Medicine Initiative)
- Metabolomics and its application to cancer epidemiology
- MicroRNAs for biomarker discovery
- Circulating nanovesicles to detect, monitor, and treat cancer
- Precision prevention and cancer disparities
- Data sharing in cancer epidemiology cohorts
- Advances in the use of technology for recruitment, retention and follow-up of research participants
During the meeting, Susan Gapstur, Ph.D., M.P.H. of the American Cancer Society, was recognized for her leadership as Chair of the NCI Cohort Consortium's
Steering Committee throughout 2016. Also recognized were Leslie Bernstein, Ph.D., of City of Hope and the Beckman Research Institute and Wei Zheng, Ph.D., M.P.H., of Vanderbilt University Medical Center, both of whom have been members of the Steering Committee since 2014. The incoming Chair for 2017 will be Anthony Swerdlow, D.M., D.Sc., of the Institute of Cancer Research, University of London.
This year's agenda included interactive sessions, formal presentations, an informal session for investigators to interact with EGRP Program directors, and a poster session.
Learn more about the role of our program directors.
|
Incoming Chair Anthony Swerdlow, D.M., D.Sc, presents awards for the poster session to Veronika Fedirko, Ph.D., M.P.H., and Anne Zeleniuch-Jacquotte, M.D., representing Tess Clendenen, Ph.D. (not pictured).
|
There were 30 posters presented by meeting participants. Two awards were given by the Steering Committee: Best Overall Poster and Best Poster by a Student or Fellow. Veronika Fedirko, Ph.D., M.P.H., of Winship Cancer Center, won the Best Overall Poster award for her poster, "Prediagnostic Circulating Vitamin D and Risk of Death After Colorectal Cancer Diagnosis: The Circulating Biomarkers of Breast and Colorectal Cancer Consortium (BBC3)" and Tess Clendenen, Ph.D., a postdoctoral fellow at the NYU Langone Medical Center, won the award for Best Poster by a Student or Fellow for her poster, "Biomarkers for Breast Cancer Risk Prediction Among Younger Women."
Results of a survey conducted earlier in the year of working groups and projects were also discussed, highlighting some challenges, such as data harmonization and suggestions for how the Steering Committee could support the activities and experiences of the working groups.
|
Camille Pottinger, M.P.H., a Cancer Research Training Award Fellow in EGRP, presents during the 2016 Annual Meeting.
|
For questions about the NCI Cohort Consortium or Annual Meeting, contact Nonye Harvey at NCI.
|
Play an Essential Role in Scientific Progress - Become an NIH Peer Reviewer
|
The
peer review process is the foundation of the NIH's extramural research enterprise, and its continued excellence depends on the ability to recruit and retain the most accomplished, broad-thinking, and creative scientists and experts to serve as peer reviewers. In a
2015 Rock Talk blog post
, Dr. Richard Nakamura, the Director of NIH Center for Scientific Review (CSR), described peer reviewers as "the lifeline of the scientific process," and noted that "nearly 24,000 reviewers participated in more than 2,500 peer review meetings" in 2014 alone.
|
The top reasons reviewers give for serving as an NIH peer reviewer, according to the Center for Scientific Review. |
Apart from giving back to the scientific community, there are other benefits for peer reviewers: gaining experiential knowledge of the peer-review process, which is valuable for researchers' own applications, as well as for mentoring early-career scientists; gaining skills in properly evaluating grant writing and scientific proposals; building and maintaining professional networks; and keeping abreast of cutting-edge science, among others.
There is also an Early Career Reviewer Program that may be of particular interest to researchers with at least two years experience as a full-time faculty member or researcher in a similar role with an active, independent program of research. Prior research funding is not required to participate in the Early Career Reviewer Program. One benefit of participating in this program is a greater understanding of how grant applications are evaluated.
In recognition of the service peer reviewers provide, the NIH has granted appointed members of study sections and peer reviewers who have participated in six qualifying NIH review meetings over an 18-month period the possibility to submit applications as soon as they develop them, rather than waiting for standard dates. This
continuous submission policy only applies to the R01, R21, and R34 grant mechanisms.
Of course, peer review requires continuous support and willingness to serve from all members of the scientific community. Qualified individuals are needed to serve on Scientific Review Groups (a.k.a. "
study sections") in the initial peer review of applications and evaluation of Research & Development (R&D) contract proposals. There are two ways to participate: the first is by committing to a full, multi-year term (typically 12 meetings) on a standing study section or Advisory Council or Board. The second is as a temporary or
ad hoc member of a permanent standing study section. (See this
NIH Guide for Grants and Contracts notice for more details).
EGRP encourages all scientists to serve as peer reviewers, especially those who have received funding from the NIH. Those who wish to learn more about the NIH peer review process, and possibly volunteer to become a reviewer, may visit the following links for more information:
|
|